Xerosis Treatment Global Market Report 2026

Xerosis treatment aims to restore moisture to the skin and repair the skin barrier to alleviate dryness, flaking, and discomfort. This typically involves the use of emollients and moisturizers to hydrate the skin and prevent further water loss. Additionally, gentle skin care practices, such as using mild, fragrance-free cleansers and avoiding hot water or aggressive scrubbing, are essential.

The primary treatments for xerosis include medications and personal care products. Medications are substances or compounds used to diagnose, treat, prevent, or manage medical conditions. These are available in various forms, including tablets, lotions, creams, ointments, and shower products. Medications help address symptoms such as roughness, tightness, itching, and flaky skin, and are used in settings including hospitals, clinics, and home care environments.

Tariffs are impacting the xerosis treatment market by increasing costs of imported raw materials and active ingredients used in medications and personal care products. Segments such as creams, lotions, and specialized moisturizers are particularly impacted, with regions like North America and Asia-Pacific facing higher import duties. This has led to increased product prices and supply chain adjustments. Positively, tariffs have encouraged local production, innovation in ingredient sourcing, and development of domestic skincare manufacturing capabilities.

The xerosis treatment market research report is one of a series of new reports from The Business Research Company that provides xerosis treatment market statistics, including xerosis treatment industry global market size, regional shares, competitors with a xerosis treatment market share, detailed xerosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the xerosis treatment industry. This xerosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The xerosis treatment market size has grown strongly in recent years. It will grow from $9.4 billion in 2025 to $9.9 billion in 2026 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to limited availability of specialized xerosis treatments, growing prevalence of dry skin conditions, increasing hospital and clinic skincare initiatives, reliance on traditional medications, low consumer awareness of advanced moisturizers.

The xerosis treatment market size is expected to see strong growth in the next few years. It will grow to $12.12 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to development of innovative emollients and humectants, expansion of dermatology and homecare settings, rising geriatric and pediatric population, increasing adoption of multi-symptom care products, integration of digital skincare monitoring solutions. Major trends in the forecast period include rising demand for moisturizers and emollients, growth in at-home skincare treatments, increasing awareness about skin hydration and care, expansion of fragrance-free and sensitive skin products, integration of multi-symptom relief products.

The projected growth of the xerosis treatment market is largely attributed to the rising healthcare expenditure. Healthcare expenditure refers to the total resources allocated to health services, including prevention, diagnosis, treatment, and disease management, by individuals, governments, and organizations. With advancements in medical technology, healthcare costs are increasing as newer diagnostic tools and treatments often involve higher development, implementation, and ongoing care costs. This increased spending enhances access to dermatological care, facilitating early diagnosis and ongoing management of xerosis through professional support and advanced treatment options. For example, in May 2024, the UK's Office for National Statistics reported that total healthcare spending grew by 5.6% in 2023, while long-term health and social care expenditure rose by 2.8% in real terms in 2022. As a result, the growing healthcare expenditure is driving the expansion of the xerosis treatment market.

The increased prevalence of chronic skin conditions is expected to propel the growth of the xerosis treatment market going forward. Chronic skin conditions are long-lasting dermatological disorders that persist for months or even years, often requiring ongoing management and causing symptoms like itching, inflammation, or skin lesions. The prevalence of chronic skin conditions is increasing primarily due to rising exposure to environmental pollutants, which trigger inflammation and weaken the skin's natural barrier. Xerosis treatment helps manage chronic skin conditions by restoring skin hydration and strengthening the skin barrier, reducing dryness and irritation while improving overall skin health. For instance, in 2023, according to the American Academy of Dermatology, a US-based non-profit organization, acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. Therefore, the increased prevalence of chronic skin conditions is driving the growth of the xerosis treatment market.

Major companies operating in the xerosis treatment market are focusing on developing technological advancements, such as dexpanthenol, to enhance skin hydration and repair. Dexpanthenol is a derivative of pantothenic acid (vitamin B5) that helps in moisturizing and repairing the skin. It penetrates the skin easily and promotes healing and regeneration. For instance, in October 2024, Bayer, a Germany-based domestic pharmaceutical and biotechnology company, launched Bepanthen in India, which aims to enhance skin hydration and promote healing of dry or damaged skin. Bayer's launch of Bepanthen in India highlighted its focus on addressing widespread dry skin, affecting nearly half of the population. The product is designed to provide deep hydration, support skin barrier repair, and promote natural skin regeneration, making it suitable for daily skincare needs.

Major companies operating in the xerosis treatment market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Unilever PLC, Bayer AG, Sanofi S.A., L'Oreal S.A., GlaxoSmithKline plc, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Galderma S.A., Dr. Reddy's Laboratories Ltd., LEO Pharma A/S, Arcutis Biotherapeutics Inc., Neutrogena, Aveeno, CeraVe, La Roche-Posay, Nivea, Cetaphil.

North America was the largest region in the xerosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xerosis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the xerosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The xerosis treatment market consists of sales of cleansing bars, body oils and barrier repair creams. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Xerosis Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses xerosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for xerosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The xerosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Medication; Personal Care Products
• 2) By Form: Tablets; Lotion; Cream; Ointment; Shower Forms; Other Forms
• 3) By Symptoms: Roughness; Tightness; Itching; Flaky Skin
• 4) By End Users: Hospitals; Clinics; Homecare Settings; Other End Users
• Subsegments:
• 1) By Medication: Topical Corticosteroids; Oral Antihistamines; Immunomodulators; Antibacterial Agents; Antifungal Agents
• 2) By Personal Care Products: Moisturizers; Emollients; Humectants; Bath Additives; Cleansers
• Companies Mentioned: Pfizer Inc.; The Procter & Gamble Company; Johnson & Johnson; Unilever PLC; Bayer AG; Sanofi S.A.; L'Oreal S.A.; GlaxoSmithKline plc; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Ltd.; Galderma S.A.; Dr. Reddy's Laboratories Ltd.; LEO Pharma A/S; Arcutis Biotherapeutics Inc.; Neutrogena; Aveeno; CeraVe; La Roche-Posay; Nivea; Cetaphil.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.